Abstract:BACKGROUND & AIMS:We performed genetic analyses of a multiethnic cohort of patients with idiosyncratic drug-induced liver injury (DILI) to identify variants associated with susceptibility.METHODS:We performed a genome-wide association study of 2048 individuals with DILI (cases) and 12,429 individuals without (controls). Our analysis included subjects of European (1806 cases and 10,397 controls), African American (133 cases and 1,314 controls), and Hispanic (109 cases and 718 controls) ancestry. We analyzed DNA from 113 Icelandic cases and 239,304 controls to validate our findings.RESULTS:We associated idiosyncratic DILI with rs2476601, a nonsynonymous polymorphism that encodes a substitution of tryptophan with arginine in the protein tyrosine phosphatase, nonreceptor type 22 gene (PTPN22) (odds ratio [OR] 1.44; 95% confidence interval [CI] 1.28-1.62; P = 1.2 × 10-9 and replicated the finding in the validation set (OR 1.48; 95% CI 1.09-1.99; P = .01). The minor allele frequency showed the same effect size (OR > 1) among ethnic groups. The strongest association was with amoxicillin and clavulanate-associated DILI in persons of European ancestry (OR 1.62; 95% CI 1.32-1.98; P = 4.0 × 10-6; allele frequency = 13.3%), but the polymorphism was associated with DILI of other causes (OR 1.37; 95% CI 1.21-1.56; P = 1.5 × 10-6; allele frequency = 11.5%). Among amoxicillin- and clavulanate-associated cases of European ancestry, rs2476601 doubled the risk for DILI among those with the HLA risk alleles A*02:01 and DRB1*15:01.CONCLUSIONS:In a genome-wide association study, we identified rs2476601 in PTPN22 as a non-HLA variant that associates with risk of liver injury caused by multiple drugs and validated our finding in a separate cohort. This variant has been associated with increased risk of autoimmune diseases, providing support for the concept that alterations in immune regulation contribute to idiosyncratic DILI.

A Loss-Of-Function Variant of Ptpn22 is Associated with Reduced Risk of Systemic Lupus Erythematosus

Association Analysis of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 in Systemic Lupus Erythematosus Families: Increased T Allele Frequency in Systemic Lupus Erythematosus Patients with Autoimmune Thyroid Disease

Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.

Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus

The Common, Autoimmunity-Predisposing 620arg > Trp Variant of PTPN22 Modulates Macrophage Function and Morphology.

P2RY8 Variants in Lupus Patients Uncover a Role for the Receptor in Immunological Tolerance

PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses

Autoimmunity-associated allele of tyrosine phosphatase gene PTPN22 enhances anti-viral immunity

LYP regulates SLP76 and other adaptor proteins in T cells

The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review

Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases

The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.

The susceptibility of single nucleotide polymorphisms located within co-stimulatory pathways to systemic lupus erythematosus

Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus

Deficiency of two-pore segment channel 2 contributes to systemic lupus erythematosus via regulation of apoptosis and cell cycle

Redox regulation of PTPN22 affects the severity of T-cell-dependent autoimmune inflammation

Lupus Risk-Variant Increases Pstat1 Binding and Decreases ETS1 Expression (BA4P.137)

Preferential Association of a Functional Variant in Complement Receptor 2 with Antibodies to Double-Stranded DNA

Substrate Specificity of Lymphoid-specific Tyrosine Phosphatase (Lyp) and Identification of Src Kinase-associated Protein of 55 kDa Homolog (SKAP-HOM) as a Lyp Substrate

TLR7 gain-of-function genetic variation causes human lupus